WVE - Wave Life Sciences Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5754.52M
Enterprise Value 3543.49M
Trailing P/E N/A
Forward P/E 1-5.19
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)40.20
Price/Book (mrq)4.71
Enterprise Value/Revenue 328.96
Enterprise Value/EBITDA 6-3.12

Trading Information

Stock Price History

Beta (3Y Monthly) 0.84
52-Week Change 3-56.33%
S&P500 52-Week Change 31.52%
52 Week High 356.00
52 Week Low 318.16
50-Day Moving Average 322.73
200-Day Moving Average 330.29

Share Statistics

Avg Vol (3 month) 3256.13k
Avg Vol (10 day) 3179.96k
Shares Outstanding 529.29M
Float 8.02M
% Held by Insiders 122.76%
% Held by Institutions 173.53%
Shares Short (Jul 31, 2019) 43.62M
Short Ratio (Jul 31, 2019) 415
Short % of Float (Jul 31, 2019) 414.97%
Short % of Shares Outstanding (Jul 31, 2019) 410.57%
Shares Short (prior month Jun 28, 2019) 43.81M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-963.29%

Management Effectiveness

Return on Assets (ttm)-30.57%
Return on Equity (ttm)-102.55%

Income Statement

Revenue (ttm)18.77M
Revenue Per Share (ttm)0.60
Quarterly Revenue Growth (yoy)56.30%
Gross Profit (ttm)-120.01M
EBITDA -173.97M
Net Income Avi to Common (ttm)-161.66M
Diluted EPS (ttm)-5.14
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)252.91M
Total Cash Per Share (mrq)7.38
Total Debt (mrq)34.01M
Total Debt/Equity (mrq)20.23
Current Ratio (mrq)2.33
Book Value Per Share (mrq)4.68

Cash Flow Statement

Operating Cash Flow (ttm)-145.14M
Levered Free Cash Flow (ttm)-30.4M